Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Incidence, Severity and Impact of Influenza: a joint meeting organised by the ISIRV Epidemiology Group and ECDC, Stockholm, 2019.

Rath B, Penttinen P.

Euro Surveill. 2020 Jun;24(23). doi: 10.2807/1560-7917.ES.2019.24.23.1900348. No abstract available.

2.

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.

Kenangalem E, Poespoprodjo JR, Douglas NM, Burdam FH, Gdeumana K, Chalfein F, Prayoga, Thio F, Devine A, Marfurt J, Waramori G, Yeung S, Noviyanti R, Penttinen P, Bangs MJ, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN.

PLoS Med. 2019 May 29;16(5):e1002815. doi: 10.1371/journal.pmed.1002815. eCollection 2019 May.

3.

Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019.

Segaloff H, Melidou A, Adlhoch C, Pereyaslov D, Robesyn E, Penttinen P, Olsen SJ; Who European Region And The European Influenza Surveillance Network.

Euro Surveill. 2019 Feb;24(9). doi: 10.2807/1560-7917.ES.2019.24.9.1900125.

4.

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.

Kissling E, Rose A, Emborg HD, Gherasim A, Pebody R, Pozo F, Trebbien R, Mazagatos C, Whitaker H, Valenciano M; European Ive Group.

Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.1900121.

5.

Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016-17.

Adlhoch C, Dabrera G, Penttinen P, Pebody R; Country Experts.

Emerg Infect Dis. 2018 Oct;24(10):1-8. doi: 10.3201/eid2410.180269. Epub 2018 Oct 17.

6.

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively.

Adlhoch C, Snacken R, Melidou A, Ionescu S, Penttinen P; The European Influenza Surveillance Network.

Euro Surveill. 2018 Mar;23(13). doi: 10.2807/1560-7917.ES.2018.23.13.18-00146.

7.

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.

Rondy M, Kissling E, Emborg HD, Gherasim A, Pebody R, Trebbien R, Pozo F, Larrauri A, McMenamin J, Valenciano M; I-MOVE/I-MOVE+ group.

Euro Surveill. 2018 Mar;23(9). doi: 10.2807/1560-7917.ES.2018.23.9.18-00086.

8.

Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016.

Broberg EK, Waris M, Johansen K, Snacken R, Penttinen P; European Influenza Surveillance Network.

Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.17-00284.

10.

Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016.

Harvala H, Jasir A, Penttinen P, Pastore Celentano L, Greco D, Broberg E.

Euro Surveill. 2017 Nov;22(45). doi: 10.2807/1560-7917.ES.2017.22.45.16-00807.

11.

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.

Vestergaard LS, Nielsen J, Krause TG, Espenhain L, Tersago K, Bustos Sierra N, Denissov G, Innos K, Virtanen MJ, Fouillet A, Lytras T, Paldy A, Bobvos J, Domegan L, O'Donnell J, Scortichini M, de Martino A, England K, Calleja N, van Asten L, Teirlinck AC, Tønnessen R, White RA, P Silva S, Rodrigues AP, Larrauri A, Leon I, Farah A, Junker C, Sinnathamby M, Pebody RG, Reynolds A, Bishop J, Gross D, Adlhoch C, Penttinen P, Mølbak K.

Euro Surveill. 2017 Apr 6;22(14). pii: 30506. doi: 10.2807/1560-7917.ES.2017.22.14.30506.

12.

Letter to the editor: Just a coincidence? Two severe human cases due to swine influenza (SIV) A(H1N1)v in Europe, October 2016.

Adlhoch C, Penttinen P.

Euro Surveill. 2017 Mar 9;22(10). pii: 30478. doi: 10.2807/1560-7917.ES.2017.22.10.30478. No abstract available.

13.

Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.

Kissling E, Rondy M; I-MOVE/I-MOVE+ study team.

Euro Surveill. 2017 Feb 16;22(7). pii: 30464. doi: 10.2807/1560-7917.ES.2017.22.7.30464.

14.

Highly pathogenic avian influenza A(H5N8) outbreaks: protection and management of exposed people in Europe, 2014/15 and 2016.

Adlhoch C, Brown IH, Angelova SG, Bálint Á, Bouwstra R, Buda S, Castrucci MR, Dabrera G, Dán Á, Grund C, Harder T, van der Hoek W, Krisztalovics K, Parry-Ford F, Popescu R, Wallensten A, Zdravkova A, Zohari S, Tsolova S, Penttinen P.

Euro Surveill. 2016 Dec 8;21(49). pii: 30419. doi: 10.2807/1560-7917.ES.2016.21.49.30419.

15.

Author's reply: Regarding the editorial by Penttinen and Friede.

Penttinen PM, Friede MH.

Euro Surveill. 2016 Oct 6;21(40). doi: 10.2807/1560-7917.ES.2016.21.40.30367. No abstract available.

16.

Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?

Penttinen PM, Friede MH.

Euro Surveill. 2016 Sep 22;21(38). doi: 10.2807/1560-7917.ES.2016.21.38.30350. No abstract available. Erratum in: Euro Surveill. 2016 Sep 29;21(39):.

17.

Observed and projected drivers of emerging infectious diseases in Europe.

Semenza JC, Rocklöv J, Penttinen P, Lindgren E.

Ann N Y Acad Sci. 2016 Oct;1382(1):73-83. doi: 10.1111/nyas.13132. Epub 2016 Jul 19. Review.

PMID:
27434370
18.

Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.

Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O; WHO European Region and the European Influenza Surveillance Network members of the reporting countries.

Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30184.

19.

Determinants and Drivers of Infectious Disease Threat Events in Europe.

Semenza JC, Lindgren E, Balkanyi L, Espinosa L, Almqvist MS, Penttinen P, Rocklöv J.

Emerg Infect Dis. 2016 Apr;22(4):581-9. doi: 10.3201/eid2204.

20.

ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation.

Penttinen P, Catchpole M.

Influenza Other Respir Viruses. 2016 May;10(3):152-3. doi: 10.1111/irv.12377. No abstract available.

21.

European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014.

Poelman R, Schuffenecker I, Van Leer-Buter C, Josset L, Niesters HG, Lina B; ESCV-ECDC EV-D68 study group.

J Clin Virol. 2015 Oct;71:1-9. doi: 10.1016/j.jcv.2015.07.296. Epub 2015 Jul 26.

22.

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group.

Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3.

23.

International infectious disease surveillance during the London Olympic and Paralympic Games 2012: process and outcomes.

Jones J, Lawrence J, Payne Hallström L, Mantero J, Kirkbride H, Walsh A, Jermacane D, Simons H, Hansford KM, Bennett E, Catchpole M; international team.

Euro Surveill. 2013 Aug 8;18(32):20554. No abstract available.

24.

Novel coronavirus associated with severe respiratory disease: case definition and public health measures.

Danielsson N; ECDC Internal Response Team, Catchpole M.

Euro Surveill. 2012 Sep 27;17(39). pii: 20282. Erratum in: Euro Surveill. 2012;17(40):pii/20287.

25.

Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps.

Nicoll A, Brown C, Karcher F, Penttinen P, Hegermann-Lindencrone M, Villanueva S, Ciotti M, Jean-Gilles L, Rehmet S, Nguyen-Van-Tam JS.

Bull World Health Organ. 2012 Apr 1;90(4):311-7. doi: 10.2471/BLT.11.097972.

26.

Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012.

Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D; European Working Group on Mycoplasma pneumoniae surveillance.

Euro Surveill. 2012 Feb 2;17(5). pii: 20075.

27.

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.

Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, Umana KG, Vemuri R, Okoseray MJ, Penttinen PM, Ebsworth P, Sugiarto P, Anstey NM, Tjitra E, Price RN.

Malar J. 2008 Aug 2;7:148. doi: 10.1186/1475-2875-7-148.

28.

Occurrence of invasive pneumococcal disease and number of excess cases due to influenza.

Grabowska K, Högberg L, Penttinen P, Svensson A, Ekdahl K.

BMC Infect Dis. 2006 Mar 20;6:58.

29.

Source-specific fine particles in urban air and respiratory function among adult asthmatics.

Penttinen P, Vallius M, Tiittanen P, Ruuskanen J, Pekkanen J.

Inhal Toxicol. 2006 Mar;18(3):191-8.

PMID:
16399661
30.

[Nipah virus--another product from the Asian "virus factory"].

Ternhag A, Penttinen P.

Lakartidningen. 2005 Apr 4-10;102(14):1046-7. Review. Swedish. No abstract available.

PMID:
15892474
31.

Mortality and air pollution in metropolitan Helsinki, 1988--1996.

Penttinen P, Tiittanen P, Pekkanen J.

Scand J Work Environ Health. 2004;30 Suppl 2:19-27.

32.

[Avian influenza--next global infection threat from Asia].

Ekdahl K, Penttinen P, Ternhag A, Linde A, Giesecke J.

Lakartidningen. 2004 Feb 19;101(8):683-5. Swedish. No abstract available.

PMID:
15024942

Supplemental Content

Loading ...
Support Center